the role of mrd in clinical decision-making in r/r cll
Published 1 year ago • 99 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
1:40
the role of mrd in decision-making in cll
-
1:39
the growing role of mrd as a clinical endpoint in cll
-
2:25
the clinical use of mrd in cll and challenges in this space
-
1:25
the role of mrd in cll
-
1:12
current role of mrd in aml
-
4:22
the role of mrd in aml
-
7:39
understanding mrd
-
5:00
venetoclax-obinutuzumab is superior to chemoimmunotherapy in frontline cll: updates from gaia/cll13
-
1:36:57
mapping the new era in cll management with precision medicine
-
1:26
the current role of mrd in aml and challenges with implementing this in clinical practice
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:30
the role of measuring mrd in cll
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
1:48
characterizing the development of mds in patients with cll in the era of targeted therapies
-
1:36
the utility of mrd for predicting treatment outcomes in patients with cll
-
0:48
the current role of mrd in cll and future outlooks
-
2:07
significance of mrd in cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:19
the prognostic value of mrd in cll
-
21:09
minimal residual disease (mrd) in cll: is it clinically relevant?
-
2:34
sequencing of therapies in patients with r/r cll
-
1:44
cll treatment duration and the role of mrd